{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:51:46Z","timestamp":1769316706981,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.clinthera.2017.07.044","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T01:15:25Z","timestamp":1503105325000},"page":"1840-1848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?"],"prefix":"10.1016","volume":"39","author":[{"given":"Rani","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Haywood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Good","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohil","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1070-1090","key":"10.1016\/j.clinthera.2017.07.044_bib1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis","volume":"51","author":"van den Beuken-van","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2017.07.044_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0885-3924(97)00006-7","article-title":"A multicenter evaluation of cancer pain control by palliative care teams","volume":"14","author":"Higginson","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2017.07.044_bib3","first-page":"1353","article-title":"Methadone treatment for pain states","volume":"71","author":"Toombs","year":"2005","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clinthera.2017.07.044_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2016.06.025","article-title":"Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer","volume":"65","author":"Haumann","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinthera.2017.07.044_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3959(93)90125-9","article-title":"Methadone in the management of cancer pain: a review","volume":"52","author":"Fainsinger","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2017.07.044_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/026921639801200111","article-title":"Opioid rotation: does it have a role?","volume":"12","author":"Twycross","year":"1998","journal-title":"Palliat Med"},{"key":"10.1016\/j.clinthera.2017.07.044_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinthera.2017.07.044_bib8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1089\/jpm.2015.0303","article-title":"A retrospective study on the effectiveness of switching to oral methadone for relieving severe cancer-related neuropathic pain and limiting adjuvant analgesic use in Japan","volume":"19","author":"Sugiyama","year":"2016","journal-title":"J Palliat Med"},{"key":"10.1016\/j.clinthera.2017.07.044_bib9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000542-198603000-00004","article-title":"A double-blind comparison of the efficacy of methadone and morphine in postoperative pain control","volume":"64","author":"Gourlay","year":"1986","journal-title":"Anesthesiology"},{"key":"10.1016\/j.clinthera.2017.07.044_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0304-3959(86)90234-4","article-title":"A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer","volume":"25","author":"Gourlay","year":"1986","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2017.07.044_bib11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1742-1241.2008.01990.x","article-title":"The role of methadone in cancer pain treatment\u2014a review","volume":"63","author":"Leppert","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2017.07.044_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone-metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clinthera.2017.07.044_bib13","series-title":"Plasma methadone level monitoring in methadone maintenance therapy: a personalised methadone therapy","author":"Mohamad","year":"2013"},{"key":"10.1016\/j.clinthera.2017.07.044_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00520-011-1147-3","article-title":"Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?","volume":"20","author":"Hardy","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clinthera.2017.07.044_bib15","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.clinthera.2015.11.002","article-title":"Saliva versus plasma for pharmacokinetic and pharmacodynamic studies of fentanyl in patients with cancer","volume":"37","author":"Bista","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2017.07.044_bib16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1177\/0091270003257229","article-title":"Influence of simulated weightlessness on the oral pharmacokinetics of acetaminophen as a gastric emptying probe in man: a plasma and a saliva study","volume":"43","author":"Gandia","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.07.044_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/j.1552-4604.1987.tb03082.x","article-title":"Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva\/plasma ratio and clinical effects","volume":"27","author":"Ritschel","year":"1987","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.07.044_bib18","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1515\/CCLM.2004.248","article-title":"Oral fluid as a diagnostic tool","volume":"42","author":"Choo","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clinthera.2017.07.044_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00542102","article-title":"Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method","volume":"20","author":"Meresaar","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.07.044_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-6576.1982.tb01850.x","article-title":"Clinical pharmacokinetics of methadone","volume":"74","author":"Nilsson","year":"1982","journal-title":"Acta Anaesthesiol Scand Suppl"},{"key":"10.1016\/j.clinthera.2017.07.044_bib21","first-page":"1","article-title":"Saliva as an analytical tool in toxicology","volume":"1","author":"Hold","year":"1996","journal-title":"Int J Drug Test"},{"key":"10.1016\/j.clinthera.2017.07.044_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.ftd.0000164392.01779.db","article-title":"Can saliva replace plasma for the monitoring of methadone?","volume":"27","author":"Shiran","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2017.07.044_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1300\/J069v20n02_05","article-title":"Therapeutic drug monitoring in methadone maintenance: choosing a matrix","volume":"20","author":"Moolchan","year":"2001","journal-title":"J Addict Dis"},{"key":"10.1016\/j.clinthera.2017.07.044_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3959(83)90143-4","article-title":"Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases","volume":"17","author":"Daut","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2017.07.044_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.talanta.2015.11.044","article-title":"Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection","volume":"149","author":"George","year":"2016","journal-title":"Talanta"},{"key":"10.1016\/j.clinthera.2017.07.044_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/23.6.452","article-title":"Correlation of saliva codeine concentrations with plasma concentrations after oral codeine administration","volume":"23","author":"O'Neal","year":"1999","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinthera.2017.07.044_bib27","first-page":"108","article-title":"Heroin metabolites detection in saliva and blood","volume":"20","author":"Pourzitaki","year":"2006","journal-title":"Rev Clin Pharmacol Pharmacokinet"},{"key":"10.1016\/j.clinthera.2017.07.044_bib28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00007691-199710000-00008","article-title":"Correlation of morphine sulfate in blood plasma and saliva in pediatric patients","volume":"19","author":"Kopecky","year":"1997","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2017.07.044_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/PL00007717","article-title":"Saliva testing after single and chronic administration of dihydrocodeine","volume":"114","author":"Skopp","year":"2001","journal-title":"Int J Legal Med"},{"key":"10.1016\/j.clinthera.2017.07.044_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2016.0311","article-title":"A phase I study of D-methadone in patients with chronic pain","volume":"12","author":"Moryl","year":"2016","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.clinthera.2017.07.044_bib31","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/clinchem\/37.7.1297","article-title":"Methadone in saliva","volume":"37","author":"Wolff","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2017.07.044_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jat\/24.1.70","article-title":"Saliva\/plasma ratio of methadone and EDDP","volume":"24","author":"Bermejo","year":"2000","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinthera.2017.07.044_bib33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0090-9556(25)06089-1","article-title":"The secretion of methadone and its major metabolite in the gastric juice of humans: comparison with blood and salivary concentrations","volume":"4","author":"Lynn","year":"1976","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinthera.2017.07.044_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0378-4347(00)81856-3","article-title":"Analysis of methadone and metabolites in biological fluids with gas chromatography\u2014mass spectrometry","volume":"231","author":"Kang","year":"1982","journal-title":"J Chromatogr"},{"key":"10.1016\/j.clinthera.2017.07.044_bib35","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1373\/clinchem.2008.108670","article-title":"Oral fluid testing for drugs of abuse","volume":"55","author":"Bosker","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2017.07.044_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/0972-124X.118317","article-title":"Salivary pH: a diagnostic biomarker","volume":"17","author":"Baliga","year":"2013","journal-title":"J Indian Soc Periodontol"},{"key":"10.1016\/j.clinthera.2017.07.044_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1476-5381.1977.tb07719.x","article-title":"Characterization of (+\/-)-methadone uptake by rat lung","volume":"59","author":"Chi","year":"1977","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2017.07.044_bib38","article-title":"Correlation of methadone concentrations in plasma and saliva collected with and without stimulation in pain management patients","author":"Miguez-Diez","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clinthera.2017.07.044_bib39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000107104","article-title":"In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites","volume":"80","author":"Crettol","year":"2007","journal-title":"Pharmacology"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181730869X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181730869X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:33:56Z","timestamp":1750808036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929181730869X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S014929181730869X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.07.044","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}